Differences of survival benefits brought by various treatments in ovarian cancer patients with different tumor stages
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differences of survival benefits brought by various treatments in ovarian cancer patients with different tumor stages
Authors
Keywords
-
Journal
Journal of Ovarian Research
Volume 16, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-05-11
DOI
10.1186/s13048-023-01173-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rapid triage for ischemic stroke: a machine learning-driven approach in the context of predictive, preventive and personalised medicine
- (2022) Yulu Zheng et al. EPMA Journal
- Estimation of Heterogeneous Restricted Mean Survival Time Using Random Forest
- (2021) Mingyang Liu et al. Frontiers in Genetics
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Modeling successive birth interval of women in Ethiopia: application of parametric shared frailty and accelerated failure time model
- (2021) Nuru Muhammed Mustefa et al. BMC Womens Health
- A Novel Clinical Nomogram for Predicting Cancer-Specific Survival in Adult Patients After Primary Surgery for Epithelial Ovarian Cancer: A Real-World Analysis Based on the Surveillance, Epidemiology, and End Results Database and External Validation in a Tertiary Center
- (2021) Xianli Li et al. Frontiers in Oncology
- Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study
- (2021) Bo Wang et al. BMC CANCER
- Why restricted mean survival time methods are especially useful for non-inferiority trials
- (2021) Matteo Quartagno et al. Clinical Trials
- Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapy
- (2021) Angelina Tjokrowidjaja et al. EUROPEAN JOURNAL OF CANCER
- Robust estimation and variable selection for the accelerated failure time model
- (2021) Yi Li et al. STATISTICS IN MEDICINE
- A nomogram to predict the cancer‐specific survival of stage II–IV Epithelial ovarian cancer after bulking surgery and chemotherapy
- (2021) Ling Zhao et al. Cancer Medicine
- Comparison of the sixth, seventh, and eighth editions of the American Joint Committee on Cancer Tumor-Node-Metastasis staging system for gastric cancer
- (2021) Mei-Wen Chen et al. MEDICINE
- Biobanks in the era of big data: objectives, challenges, perspectives, and innovations for predictive, preventive, and personalised medicine
- (2020) Judita Kinkorová et al. EPMA Journal
- Accelerated Failure Time Survival Model to Analyze Morris Water Maze Latency Data
- (2020) Clark R. Andersen et al. JOURNAL OF NEUROTRAUMA
- Accelerated failure time model for data from outcome-dependent sampling
- (2020) Jichang Yu et al. LIFETIME DATA ANALYSIS
- On the restricted mean survival time curve in survival analysis
- (2015) Lihui Zhao et al. BIOMETRICS
- Predictive, Preventive and Personalised Medicine as the hardcore of ‘Horizon 2020’: EPMA position paper
- (2014) Olga Golubnitschaja et al. EPMA Journal
- Predicting the restricted mean event time with the subject's baseline covariates in survival analysis
- (2013) L. Tian et al. BIOSTATISTICS
- Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer
- (2013) Rong Hu et al. EPMA Journal
- A Comparison Between the Seventh and Sixth Editions of the American Joint Committee on Cancer/International Union Against Classification of Gastric Cancer
- (2012) Jizhun Zhang et al. ANNALS OF SURGERY
- Assessment of the American Joint Committee on Cancer Staging (sixth and seventh editions) for clinically localized prostate cancer treated with external beam radiotherapy and comparison with the National Comprehensive Cancer Network risk-stratification me
- (2012) Nicholas G. Zaorsky et al. CANCER
- Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker
- (2012) Karel G M Moons et al. HEART
- Long-term survival in patients with clear cell adenocarcinoma of ovary treated with irinotecan hydrochloride plus cisplatin therapy as first-line chemotherapy
- (2012) Shiro Kunito et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Ten-Year Relative Survival for Epithelial Ovarian Cancer
- (2012) Lauren A. Baldwin et al. OBSTETRICS AND GYNECOLOGY
- General Report & Recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper of the European Association for Predictive, Preventive and Personalised Medicine
- (2012) Olga Golubnitschaja et al. EPMA Journal
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started